IGC Pharma, Inc. IGC
AMEX · United States · Health Technology
$0.2750+0.01 (+1.85%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.03 | -0.02 | -50.0% | $265.00K | +61.6% | -3.4%$0.29→$0.28 |
| Q1 2026 | 2026-05-15 | -0.02 | -0.02 | 0.0% | — | — | -3.3%$0.30→$0.29 |
| Q4 2025 | 2025-06-27 | -0.01 | -0.02 | +50.0% | — | — | — |
| Q3 2025 | 2025-02-14 | -0.02 | -0.03 | +33.3% | — | — | — |
| Q2 2025 | 2024-11-12 | -0.02 | -0.03 | +33.3% | — | — | — |
| Q1 2025 | 2024-08-07 | -0.03 | -0.03 | 0.0% | — | — | — |
| Q4 2024 | 2024-06-24 | -0.03 | -0.04 | +25.0% | — | — | — |
| Q3 2024 | 2024-02-14 | -0.05 | -0.04 | -25.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.